Literature DB >> 10626032

Response to nicotine dependence treatment in smokers with current and past alcohol problems.

J T Hays1, D R Schroeder, K P Offord, I T Croghan, C A Patten, R D Hurt, D E Jorenby, M C Fiore.   

Abstract

Smoking prevalence among alcoholics is high, and evidence indicates that smokers with a history of alcohol abuse may have more difficulty quitting cigarette smoking. This study is a post hoc analysis comparing the smoking cessation rates of smokers with active or past alcohol problems to the rates in smokers with no history of alcohol problems who were participants in a randomized, controlled trial of smoking cessation therapy. Subjects received either 44 mg/24 hour or 22 mg/24 hour nicotine patch for 4 or 6 weeks, respectively, followed by a tapering schedule to complete 8 weeks of therapy and a randomly assigned behavioral intervention (minimal, brief individual counseling, group therapy). The Self-Administered Alcoholism Screening Test (SAAST) score was used to determine alcohol group assignment (no alcohol problems < 7; active alcohol problems > or = 7 and still drinking; past alcohol problems if not drinking due to a past history of alcohol problems). Among 382 subjects (171 men and 211 women), 281 had no alcohol problems (74%), 53 had past alcohol problems (14%), and 48 had active alcohol problems (13%). Smoking cessation rates assessed at both weeks 4 and 8 were significantly different across groups (p = 0.026 and 0.002 at weeks 4 and 8, respectively) with lower rates in the groups with past and active alcohol problems when compared to the "no problem" group. At week 26, subjects with past alcohol problems were less likely to be abstinent from smoking than no problem group subjects, but this was not statistically significant (odds ratio = 0.49, 95% confidence interval 0.22-->1.08). In the short term, smokers with past or active alcohol problems are less likely to quit smoking compared to those with no alcohol problems when treated with nicotine patch therapy for smoking cessation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626032     DOI: 10.1007/BF02884841

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  39 in total

1.  Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones.

Authors:  Adam M Leventhal; Sandra J Japuntich; Megan E Piper; Douglas E Jorenby; Tanya R Schlam; Timothy B Baker
Journal:  Psychol Addict Behav       Date:  2012-05-28

Review 2.  Pharmacologic agents for tobacco dependence treatment: 2011 update.

Authors:  J Taylor Hays; David D McFadden; Jon O Ebbert
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

Review 3.  Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review.

Authors:  Joseph Guydish; Emma Passalacqua; Barbara Tajima; Sarah Turcotte Manser
Journal:  J Psychoactive Drugs       Date:  2007-12

4.  Smoking patterns, quit behaviors, and smoking environment of workers in small manufacturing companies.

Authors:  Erika A Pinsker; Deborah J Hennrikus; Peter J Hannan; Harry A Lando; Lisa M Brosseau
Journal:  Am J Ind Med       Date:  2015-07-14       Impact factor: 2.214

5.  Examining the effects of illicit drug use on tobacco cessation outcomes in the Helping HAND 2 randomized controlled trial.

Authors:  Joanna M Streck; Susan Regan; Yuchiao Chang; Jennifer H K Kelley; Daniel E Singer; Nancy A Rigotti
Journal:  Drug Alcohol Depend       Date:  2017-07-08       Impact factor: 4.492

Review 6.  Current perspectives on smoking cessation among substance abusers.

Authors:  Maria A Sullivan; Lirio S Covey
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

7.  Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: a naturalistic, open-label study.

Authors:  Maher Karam-Hage; Jason D Robinson; Ashutosh Lodhi; Kirk J Brower
Journal:  Curr Clin Pharmacol       Date:  2014-05

8.  Coadministration of intravenous nicotine and oral alcohol in rats.

Authors:  A D Lê; Steven Lo; Stephen Harding; Walter Juzytsch; Peter W Marinelli; Douglas Funk
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

9.  Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.

Authors:  Lisa Sanderson Cox; Christi A Patten; Raymond S Niaura; Paul A Decker; Nancy Rigotti; David P L Sachs; A Sonia Buist; Richard D Hurt
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

10.  Impact of vital signs screening & clinician prompting on alcohol and tobacco screening and intervention rates: a pre-post intervention comparison.

Authors:  J Paul Seale; Sylvia Shellenberger; Mary M Velasquez; John M Boltri; Ike Okosun; Monique Guyinn; Dan Vinson; Monica Cornelius; J Aaron Johnson
Journal:  BMC Fam Pract       Date:  2010-03-05       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.